title: [A reply on subsidizing of antihypertensive agents: the problem is exceptional undertreatment of hypertension].
authors.affiliation: Lunds universitet, Malmö. Ronnie.Willenheimer@med.lu.se
authors.forename: Ronnie
authors.initials: R
authors.lastname: Willenheimer
authors.forename: Fredrik
authors.initials: F
authors.lastname: Nyström
authors.forename: Bosse
authors.initials: B
authors.lastname: Berggren
authors.forename: Torbjörn
authors.initials: T
authors.lastname: Lindström
authors.forename: Stella
authors.initials: S
authors.lastname: Cizinsky
authors.forename: Lars
authors.initials: L
authors.lastname: Weiss
mesh_terms: D000959:Antihypertensive Agents / Q000191:economics / Q000627:therapeutic use*; D017281:Cost of Illness; D016527:Drug Costs; D017048:Health Care Costs; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000191:economics; D007348:Insurance, Health; D013548:Sweden
chemical_list: D000959:Antihypertensive Agents